Westlake Therapeutics
Westlake Therapeutics
Explore linked clinical trials.3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Allogeneic WTX-212C in Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Early phase 1 | 2026-07-14 | NCT07556653 | |
| A Phase I Study of WTX212A Monotherapy or in Combination With Radiotherapy in Patients With Advanced Solid Tumors | cancer, neoplasm | Recruiting | Phase 1 | 2025-12-08 | NCT07269899 | |
| Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies | Hemic and Lymphatic Diseases, Neoplasms by Site, cancer, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Not yet recruiting | Phase 1 | 2024-07-30 | NCT06528249 |